Metethoheptazine

This classification denotes an opioid receptor agonist with the molecular formula C17H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S36J5ZY2TH, chemically known as 1,3-dimethyl-4-carbethoxy-4-phenylhexamethylenimin but generally known as metethoheptazine, which bears US NIH Compound Identifier 176888. European Medicines Agency schedules Metethoheptazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08829MIG. The term METETHOHEPTAZINE is an International Non-Proprietary Name. METETHOHEPTAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metethoheptazine under HS 29339930 and SITC 51577. As of Q4 2014, METETHOHEPTAZINE remains the US FDA Preferred Term for this commodity. Metethoheptazine bears US NLM identifiers UMLS ID C2983999 and NCI Concept Code C91044. SMILES: O(C(=O)C1(C(CN(CCC1)C)C)C1CCCCC1)CC.